Effects of the VEGFR-2 Tyrosine Kinase Inhibitor ZD6474 and Docetaxel on Circulating Endothelial Cells (CEC): Implications for Use as a Surrogate Marker

Conference Paper

Duke Authors

Cited Authors

  • Force, JM; Heymach, JV; Beaudry, B; Wang, AC; Baker, C; Ryan, A; Folkman, J; Soker, S

Conference Name

  • Proc AACR/NCI/EORTC Mol Targ and Canc Therapeutics

Conference Start Date

  • 2003

Conference End Date

  • 2003